Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 19/7/2019
SIETES contiene 92793 citas

 
 
 1 a 20 de 37 siguiente >>
Presentar resultados
Seleccionar todas
1.Enlace a cita original Cita con resumen
Bersoff-Matcha SJ, Chamberlain C, Cao C, Kortepeter C, Chong WH. Fournier gangrene associated with sodium–glucose cotransporter-2 inhibitors: a review of spontaneous postmarketing cases. Ann Intern Med 2019:7 de mayo. [Ref.ID 103108]
2.Enlace a cita original Cita con resumen
Ueda P, Svanström H, Melbye M, Eliasson B, Svensson A-M, Franzén S, Gudbjörnsdottir S, Hveem K, Jonasson C, Pasternak B. Sodium glucose cotransporter 2 inhibitors and risk of serious adverse events: nationwide register based cohort study. BMJ 2018;363:14 de noviembre. [Ref.ID 102869]
3.Enlace a cita original Cita con resumen
Chang HY, Singh S, Mansour O, Baksh S, Alexander GC. Association between sodium-glucose cotransporter 2 inhibitors and lower extremity amputation among patients with type 2 diabetes. JAMA Intern Med 2018:13 de agosto. [Ref.ID 102824]
6.Enlace a cita originalTiene citas relacionadas
Montori VM. Selecting the right drug treatment for adults with type 2 diabetes. BMJ 2016;352:i1663. [Ref.ID 100301]
9. Cita con resumen
Dyer O. Experimental drug that injured UK volunteers resumes in human trials. BMJ 2015;350:h1831. [Ref.ID 98941]
10.Enlace a cita original Cita con resumen
Boussageon R, Supper I, Bejan-Angoulvant T, Kellou N, Cucherat M, Boissel J-P, Kassai B, Moreau A, Gueyffier F, Cornu C. Reappraisal of metformin efficacy in the treatment of type 2 diabetes: a meta-analysis of randomised controlled trials. PLOS Medicine 2012:abril. [Ref.ID 92585]
11.Tiene citas relacionadas Cita con resumen
Belch J, Hiatt WR, Baumgartner I, Driver IV, Nikol S, Norgren L, Van Belle E, on behalf of the TAMARIS Committees and Investigators. Effect of fibroblast growth factor NV1FGF on amputation and death: a randomised placebo-controlled trial of gene therapy in critical limb ischaemia. Lancet 2011;377:1929-37. [Ref.ID 91294]
12.Tiene citas relacionadas
Fowkes FGR, Price JF. Gene therapy for critical limb ischaemia: the TAMARIS trial. Lancet 2011;377:1894-6. [Ref.ID 91288]
13. Cita con resumen
Bilik D, McEwen LN, Brown MB, Pomeroy NE, Kim C, Asao K, Crosson JC, Duru OK, Ferrara A, Hsiao VC, Karter AJ, Lee PG, Marrero DG, Selby JV, Subramanian U, Herman WH. Thiazolidinediones and fractures: evidence from translating research into action for diabetes. J Clin Endocrinol Metab 2010;95:4560-5. [Ref.ID 89233]
14. Cita con resumen
Rubio JA, Salido C, Albarracín A, Jiménez S, Álvarez J. Incidencia de amputaciones de extremidades inferiores en el área 3 de Madrid. Estudio retrospectivo del periodo 2001-2006. Rev Clin Esp 2010;210:65-9. [Ref.ID 88046]
15.Tiene citas relacionadas Cita con resumen
Home PD, Pocock SJ, Beck-Nielsen H, Curtis PS, Gomis R, Hanefeld M, Jones NP, Komajda M, McMurray JJV, for the RECORD Study Team. Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial. Lancet 2009;373:2125-35. [Ref.ID 86100]
16.Tiene citas relacionadas Cita con resumen
Retnakaran R, Zinman B. Thiazolidinediones and clinical outcomes in type 2 diabetes. Lancet 2009;373:2088-90. [Ref.ID 86092]
17.Tiene citas relacionadas
Rajamani K, Colman PG, Li LP, Best JD, Voysey M, D'Emden M, Laakso M, Baker JR, Keech AC, on behalf of the FIELD study investigators. Effect of fenofibrate on amputation events in people with type 2 diabetes mellitus (FIELD study): a prespecified analysis of a randomised controlled trial. Lancet 2009;373:1780-8. [Ref.ID 85923]
18.Tiene citas relacionadas
Fazio S, Linton MF. Fenofibrate and risk of minor amputations in diabetes. Lancet 2009;373:1740-1. [Ref.ID 85911]
19.Tiene citas relacionadas Cita con resumen
Austen F, Woodcock J, Sasisekharan R. Contaminated heparin. The authors reply. N Engl J Med 2008;359:1293. [Ref.ID 83990]
20.Tiene citas relacionadas Cita con resumen
Greinacher A, Warkentin TE. Contaminated heparin. N Engl J Med 2008;359:1291-2. [Ref.ID 83988]
Seleccionar todas
 
 1 a 20 de 37 siguiente >>